The Iron Trap Redox Impedance Model of Thermogenesis

Redox Impedance and the Iron Trap: A Systems Model of Thermogenesis Collapse in Chronic Illness

Many chronic conditions—multiple sclerosis, autoimmunity, menopausal transition, obesity, neurodegeneration, and post-viral fatigue syndromes—share a striking pattern:

• Sudden “crash” fatigue

• Simultaneous heat and cold intolerance

• Blunted brown adipose tissue (BAT) activation

• Persistently elevated oxidative stress and ultra-weak photon emissions (UPE) despite seemingly adequate ATP production

This work introduces Redox Impedance (RII), a systems-level variable defined as the fraction of mitochondrial electron flow diverted into dissipative leak pathways—including reactive oxygen species, lipid peroxidation, and biophoton emission—rather than ATP synthesis or adaptive uncoupling.

Building on this, the Iron Trap Redox Impedance Model of Thermogenesis proposes that iron overload and chronic ferroptotic pressure drive RII to pathological levels, creating excessive “junk heat” and redox-danger signaling that destabilize hypothalamic thermoregulatory control.

The core prediction: once RII crosses a critical threshold, the central nervous system initiates a protective conservation mode suppressing SNS→BAT thermogenesis and downshifting motor and cognitive drive to limit further oxidative damage.

This redox-governed low-power state offers a unifying explanation for:

• Post-exertional collapse

• Menopausal thermoregulatory instability

• Chronic fatigue states

• Progressive neurological disengagement

Methodologically, the paper defines Redox Impedance Indices—RII_core, RII_oxidative, RII_optical—derived from oxygen-consumption partitioning, ROS yield, and UPE intensity. These enable quantitative, cross-species validation of the model.

Rather than framing chronic disease as simply energy deficiency, this framework reframes it as energy misallocation—a redox trap shaped by long-standing iron dysregulation. It opens the door to novel diagnostics, targeted thermogenic therapies, and redox-coherence interventions across aging, women’s health, and complex chronic illness.